APR 01, 2021 7:30 AM PDT

Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay

WRITTEN BY: Tara Fernandez

Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protecting against an infectious agent, such as with the flu vaccine, this cancer vaccine uses the patient’s own cancer cells to train the immune system to attack and destroy cancer.

“This is a new strategy for immunotherapy,” said University of Chicago professor and study lead Melody Swartz. “It has the potential to be more efficacious, less expensive, and much safer than many other immunotherapies. It is truly personalized medicine that has the potential to overcome many issues that arise with other treatments.” The research was published in Science Advances.

Skin cancer is the most common of all cancers, and melanomas make up just 1 percent of these. Melanomas affect melanocytes—pigment-producing cells in the upper layers of skin.

During melanoma development, tumors can start to fuse with lymphatic vessels during metastasis, allowing them to spread deeper into the skin and other parts of the body. However, Swartz and colleagues identified that tumors associated with lymphatic vessels become sensitized to immune attack, either by resident T cells or by immunotherapies. A molecule called vascular endothelial growth factor C, or VEGF-C, facilitates this interaction between melanomas and the lymphatic system.

The researchers used an animal model of melanoma, in which they genetically engineered the tumor cells to overexpress VEGF-C. Next, they irradiated the melanomas and reintroduced the dying cancer cells back into mice. They found that this step activated immune cells, which burst into action and began to target living tumor cells in the body. 

This process of “training” the immune system yielded a robust and long-lasting immune response targeted against cancer. Importantly, it also led to immunological memory: Tumor cells reintroduced into the animals nearly a year later were promptly destroyed.

“This shows that the therapy may provide long-term efficacy against metastasis and relapse,” said Swartz.

The scientists are expanding the horizons of their new vaccine, currently testing a similar strategy to treat breast and colon cancers with the aim of testing these therapies in a clinical trial setting one day.

“We think this has huge promise for the future of personalized cancer immunotherapy,” Swartz commented.

 

 

Sources: Science Advances, University of Chicago.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
NOV 16, 2020
Immunology
Australian COVID-19 vaccine is promising and could be released next year
NOV 16, 2020
Australian COVID-19 vaccine is promising and could be released next year
Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and he ...
JAN 11, 2021
Immunology
Can Immune cells contribute to Lung Diseases Severity?!
JAN 11, 2021
Can Immune cells contribute to Lung Diseases Severity?!
Macrophages are a type of immune cell that can detect and destruct bacteria, viruses, and harmful materials. They a ...
JAN 26, 2021
Immunology
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
JAN 26, 2021
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
In a period of just over three weeks, over four million people received Moderna’s COVID-19 vaccine. Out of all the ...
MAR 04, 2021
Immunology
Climate Change Tightens Its Grip on Hay Fever Sufferers
MAR 04, 2021
Climate Change Tightens Its Grip on Hay Fever Sufferers
There’s bad news for pollen allergy sufferers: New research has shown that climate change is making hay fever seas ...
MAR 04, 2021
Immunology
Why Do We Need Two Shots of the COVID Vaccine?
MAR 04, 2021
Why Do We Need Two Shots of the COVID Vaccine?
Unlike social distancing, mask-wearing, and hand hygiene, vaccines are our best bet as a long-term solution to protectin ...
Loading Comments...